Alexza Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alexza Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH17617D
  • |
  • Pages: 29
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous system diseases. The company develops all its products based on its own proprietary technology, Staccato system (a hand-held inhaler), which is the foundation for Adasuve (loxapine), and all other product candidates. The company's lead product Adasuve (Staccato loxapine) is indicated for the treatment of agitation associated with schizophrenia or bipolar I disorder. The company's pipeline products consist of AZ-002 (Staccato alprazolam) for acute repetitive seizures and AZ-007 (Staccato zaleplon) for insomnia. Alexza is headquartered in Mountain View, California, the US.

Alexza Pharmaceuticals Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Alexza Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Alexza Pharma Amends Co-Marketing Agreement with Grupo Ferrer International for Adasuve 11

Alexza Amends Co-Marketing Agreement with Grupo Ferrer International for Adasuve 12

Licensing Agreements 13

Lee's Pharma Enters into Licensing Agreement with Alexza Pharma 13

Engage Therapeutics Enters into Licensing Agreement with Alexza Pharma 14

Equity Offering 15

Alexza Pharma Raises USD5 million in Equity Offering 15

Alexza Pharma Completes Private Placement Of Shares For USD 6.4 Million 16

Alexza Pharma Completes Private Placement Of Shares For USD 5.5 Million 17

Alexza Pharma Completes Private Placement Of Shares For USD 3 Million 19

Alexza Pharma Completes Public Offering Of Common Stock For USD 22 Million 20

Debt Offering 21

Alexza Pharma Completes Private Placement Of Notes Due 2027 For USD 45 Million 21

Asset Transactions 22

Galen Acquires US Rights to ADASUVE from Alexza Pharma 22

Acquisition 23

Grupo Ferrer Acquires Alexza Pharma 23

Alexza Pharmaceuticals Inc-Key Competitors 26

Alexza Pharmaceuticals Inc-Key Employees 27

Alexza Pharmaceuticals Inc-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29

List of Figures

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Alexza Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alexza Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Alexza Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Alexza Pharma Amends Co-Marketing Agreement with Grupo Ferrer International for Adasuve 11

Alexza Amends Co-Marketing Agreement with Grupo Ferrer International for Adasuve 12

Lee's Pharma Enters into Licensing Agreement with Alexza Pharma 13

Engage Therapeutics Enters into Licensing Agreement with Alexza Pharma 14

Alexza Pharma Raises USD5 million in Equity Offering 15

Alexza Pharma Completes Private Placement Of Shares For USD 6.4 Million 16

Alexza Pharma Completes Private Placement Of Shares For USD 5.5 Million 17

Alexza Pharma Completes Private Placement Of Shares For USD 3 Million 19

Alexza Pharma Completes Public Offering Of Common Stock For USD 22 Million 20

Alexza Pharma Completes Private Placement Of Notes Due 2027 For USD 45 Million 21

Galen Acquires US Rights to ADASUVE from Alexza Pharma 22

Grupo Ferrer Acquires Alexza Pharma 23

Alexza Pharmaceuticals Inc, Key Competitors 26

Alexza Pharmaceuticals Inc, Key Employees 27

Alexza Pharmaceuticals Inc, Subsidiaries 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 250 INR 17815
Site License
USD 500 INR 35630
Corporate User License
USD 750 INR 53445

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com